Literature DB >> 21268129

Association of cyclin D1 gene polymorphisms with risk of esophageal squamous cell carcinoma in Kashmir Valley: a high risk area.

Showket Hussain1, Yuvaraj M, Nisha Thakur, Irfana Salam, Neha Singh, Mohammad Muzaffar Mir, Mohammad Akbar Bhat, Mushtaq A Siddiqi, Bhudev C Das, Mausumi Bharadwaj.   

Abstract

Investigation of potential association of SNPs (G870A, rs9344; G1722C, rs678653) of cyclin D1 gene (CCND1) with susceptibility to esophageal squamous cell carcinoma (ESCC) in Kashmir valley (India). The study included 302 subjects comprising 151 ESCC cases and 151 controls. PCR-RFLP and direct sequencing were employed for genotyping. The G870A polymorphism, the individuals carrying GA + AA genotype was having 2.80-fold increased risk for development of ESCC (OR 2.8, 95% CI = 1.77-4.4; P = 0.0001) compared to GG genotype. Further a significantly higher risk was observed in individuals who consume >3 cups per day of salted tea (OR = 5.1; 95% CI = 1.6-16.7; P = 0.0016) and had smoking habits (OR = 6.3; 95% CI = 2.9-13.9; P = 0.0005). We also demonstrate for the first time in CCND1 1722 locus, the CC genotype was strongly associated with increased risk of developing ESCC (OR = 2.58; 95% CI = 1.61-4.15; P = 0.0001). In addition, the frequency of polymorphic C allele was also found to be higher in cases (OR = 1.92; 95% CI = 1.37-2.69; P = 0.0002). There appears to be an influence of CCND1 G870A/G1772C genotypes on genetic susceptibility to ESCC.
Copyright ©2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21268129     DOI: 10.1002/mc.20732

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  13 in total

Review 1.  Colorectal cancer: a researcher's perspective of the molecular angel's gone eccentric in the Vale of Kashmir.

Authors:  Aga Syed Sameer
Journal:  Tumour Biol       Date:  2013-02-17

2.  The significant association of CCND1 genotypes with colorectal cancer in Taiwan.

Authors:  Chung-Yu Huang; Chia-Wen Tsai; Chin-Mu Hsu; Wen-Shin Chang; Hao-Ai Shui; Da-Tian Bau
Journal:  Tumour Biol       Date:  2015-03-26

3.  Predictive role of XRCC5/XRCC6 genotypes in digestive system cancers.

Authors:  Mei-Due Yang; Chia-Wen Tsai; Wen-Shin Chang; Yung-An Tsou; Cheng-Nan Wu; Da-Tian Bau
Journal:  World J Gastrointest Oncol       Date:  2011-12-15

4.  CCND1 G870A polymorphism contributes to the risk of esophageal cancer: An updated systematic review and cumulative meta-analysis.

Authors:  Li Wen; Yuan-Yuan Hu; Gong-Li Yang; DE-Xi Liu
Journal:  Biomed Rep       Date:  2014-05-21

Review 5.  Epidemiology of esophageal cancer.

Authors:  Yuwei Zhang
Journal:  World J Gastroenterol       Date:  2013-09-14       Impact factor: 5.742

6.  Genetic polymorphism of CCND1 G870A and esophageal cancer susceptibility: A meta-analysis.

Authors:  Wenwu He; Yanbei Zeng; Jianxiong Long; Qiuxi Zhou; Yanling Hu; Mingwu Chen
Journal:  Biomed Rep       Date:  2012-12-20

7.  Lack of association between cyclin D1 A870G (rs9344) polymorphism and esophageal squamous cell carcinoma risk: case-control study and meta-analysis.

Authors:  Weifeng Tang; Ping Yu; Yafeng Wang; Mingqiang Kang; Bin Sun; Jun Yin; Haiyong Gu
Journal:  Int J Clin Exp Med       Date:  2015-08-15

8.  Overexpression of OLC1 promotes tumorigenesis of human esophageal squamous cell carcinoma.

Authors:  Xiao Li; Jing Suo; Shujuan Shao; Liyan Xue; Wei Chen; Lijia Dong; Ji Shi; Ming Fu; Ning Lu; Qimin Zhan; Tong Tong
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

9.  Association between the Cyclin D1 G870A polymorphism and the susceptibility to and prognosis of upper aerodigestive tract squamous cell carcinomas: an updated meta-analysis.

Authors:  Yichen Meng; Chenglin Zhang; Xuhui Zhou
Journal:  Onco Targets Ther       Date:  2016-01-19       Impact factor: 4.147

10.  Predicting malignant transformation of esophageal squamous cell lesions by combined biomarkers in an endoscopic screening program.

Authors:  Hao Zhang; Hao Li; Qing Ma; Fang-Yan Yang; Tao-Yu Diao
Journal:  World J Gastroenterol       Date:  2016-10-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.